The new process improvement research of injection grade lansoprazole won the new product and new technology certificate of Guangxi Zhuang Autonomous Region.
2019
New formulation and API workshops were passed GMP inspection; Intellectual property management system was authenticated.
2018
Acquired land and infrastructure from Guangxi Kelun Pharmaceutical Co., Ltd.
2017
New warehouse and tank yard was completed.
2016
Office building was completed.
2015
Initiated plant extension and reconstruction project; obtained Lansoprazole CEP certificate.
2014
Authenticated as a national high-tech enterprise.
2013
Passed 3 GMP inspection of capsules, granules, ointment, and Venlafaxine Hydrochloride API.
2011
Passed GMP inspection of first formulation product Valsartan Dispersible Tablets.
2009
Founded in Lingchuan Guilin, passed GMP inspection of Lansoprazole API.
EN